NCT00003099View on ClinicalTrials.gov

Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 1996

Primary Completion Date

June 30, 2000

Study Completion Date

January 31, 2003

Conditions
Breast Cancer
Interventions
DRUG

Fenretinide

Daily for 14-28 days.

DRUG

Tamoxifen Citrate

Daily for 14-28 days.

OTHER

Placebo

Daily for 14-28 days

Trial Locations (1)

77030

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00003099 - Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer | Biotech Hunter | Biotech Hunter